EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Considerations for paediatric patients

Peter Foley iD, Patrick D Mahar iD, Saxon D Smith iD, Monisha Gupta iD, Nicholas Manuelpillai iD, David Orchard iD, Li-Chuen Wong iD, John C Su iD, Amelia James iD, Gayle Fischer iD, Gillian Marshman iD, Morton Rawlin iD und 4 weitere

Australasian Journal of Dermatology · 2024

DOI: 10.1111/ajd.14303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australasian Journal of Dermatology, 2024. Verfasst von Peter Foley und 15 weiteren Autor:innen. Beteiligte Einrichtung: Skin Health Institute, Carlton, Victoria, Australia. Hauptthemen laut MEDLINE: Psoriasis, Severity of Illness Index, Delphi Technique, Consensus. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janssen Pharmaceuticals, Janssen Pharmaceutica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Treatment goals have been established in Australia to facilitate the management of adults with moderate to severe psoriasis. The Australasian College of Dermatologists sought to determine if and how these adult treatment goals could be modified to accommodate the needs of paediatric and adolescent patients.

Methods

A modified Delphi approach was used. Comprehensive literature review and guideline evaluation resulted in the development of statements and other questions to establish current clinical practices. Two rounds of anonymous voting were undertaken, with a collaborative meeting held in between to discuss areas of discordance. Overall, consensus was defined as achievement of ≥75% agreement in the range 7–9 on a 9‐point scale (1 strongly disagree; 9 strongly agree).

Results

Consensus was achieved on 23/29 statements in round 1 and 17/18 statements in round 2. There was a high level of concordance with treatment criteria in the adult setting. The limitations of applying assessment tools developed for use in adult patients to the paediatric setting were highlighted. Treatment targets in the paediatric setting should include objective metrics for disease severity and psychological impact on the patients and their family, and be based on validated, age‐appropriate tools.

Conclusion

While the assessment, classification and management of moderate to severe psoriasis in paediatric patients aligns with metrics established for adults, it is vital that nuances in the transition from childhood to adolescence be taken into account. Future research should focus on psoriasis severity assessment scales specific to the paediatric setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisSeverity of Illness IndexDelphi TechniqueConsensusHumansChildAustraliaAdolescentPatient Care Planning

Stichwörter der Autor:innen

Australiaadolescentchildconsensuspaediatricpatient acuitypsoriasisquality of lifetreatment goals

Autor:innen und Institutionen

  • Skin Health Institute, Carlton, Victoria, Australia.
  • Department of Dermatology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.
  • The University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Dermatology, The Royal Children's Hospital, Parkville, Victoria, Australia.
  • Sydney Adventist Hospital Clinical School, ANU College of Health and Medicine, The Australian National University, Canberra, Australian Capital Territory, Australia.
  • The Dermatology and Skin Cancer Centre, St Leonards, New South Wales, Australia.

ORCID-Profile: Peter Foley, Patrick D Mahar, Saxon D Smith, Monisha Gupta, Nicholas Manuelpillai, David Orchard, Li-Chuen Wong, John C Su, Amelia James, Gayle Fischer, Gillian Marshman, Morton Rawlin, Murray Turner, Emma King, Robyn Kennedy, Christopher Baker

Förderung

  • Janssen Pharmaceuticals
  • Janssen Pharmaceutica

Zitieren

APA

Foley, P., Mahar, P. D., Smith, S. D., Gupta, M., Manuelpillai, N., Orchard, D., Wong, L. C., Su, J. C., James, A., Fischer, G., Marshman, G., Rawlin, M., Turner, M., King, E., Kennedy, R., & Baker, C. (2024). Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Considerations for paediatric patients. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.14303

Vancouver

Foley P, Mahar PD, Smith SD, Gupta M, Manuelpillai N, Orchard D, et al. Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Considerations for paediatric patients. Australasian Journal of Dermatology. 2024. doi:10.1111/ajd.14303

BibTeX
@article{Foley2024,
  author = {Foley, Peter and Mahar, Patrick D and Smith, Saxon D and Gupta, Monisha and Manuelpillai, Nicholas and Orchard, David and Wong, Li-Chuen and Su, John C and James, Amelia and Fischer, Gayle and Marshman, Gillian and Rawlin, Morton and Turner, Murray and King, Emma and Kennedy, Robyn and Baker, Christopher},
  title = {Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Considerations for paediatric patients},
  journal = {Australasian Journal of Dermatology},
  year = {2024},
  doi = {10.1111/ajd.14303}
}
Kostenlos starten →